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Abstract
T lymphocytes of the CD8+ class are critical in delivering cytotoxic function and in controlling viral and intracellular
infections. These cells are ‘‘helped’’ by T lymphocytes of the CD4+ class, which facilitate their activation, clonal expansion,
full differentiation and the persistence of memory. In this study we investigated the impact of CD4+ T cells on the location
of CD8+ T cells, using antibody-mediated CD4+ T cell depletion and imaging the antigen-driven redistribution of
bioluminescent CD8+ T cells in living mice. We documented that CD4+ T cells influence the biodistribution of CD8+ T cells,
favoring their localization to abdominal lymph nodes. Flow cytometric analysis revealed that this was associated with an
increase in the expression of specific integrins. The presence of CD4+ T cells at the time of initial CD8+ T cell activation also
influences their biodistribution in the memory phase. Based on these results, we propose the model that one of the
functions of CD4+ T cell ‘‘help’’ is to program the homing potential of CD8+ T cells.
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Introduction
Immune responses against viruses and intracellular pathogens
are often delivered by CD8+ cytotoxic effector cells, which kill the
pathogen-infected cell and generally the pathogen too. However
CD4+ ‘‘helper’’ T cells contribute to the function of CD8+ T cells
in such infections. A striking example is found in Hepatitis C Virus
infection, where the capacity of both humans and chimpanzees
infected with the virus to achieve suppression of viremia is strongly
correlated with the strength and diversity of the CD4+ T cell
response [1,2,3].
The mechanism of CD4+ T cell help in CD8+ T cell responses
is complex, and incompletely understood. One important
mechanism of action may be via an interaction with antigen-
presenting cells, termed licensing. In this interaction, the CD4+ T
cell undergoes antigen-specific interaction in which it delivers
CD40-mediated signals that promote the maturation and function
of an antigen-presenting cell [4]. This cell can subsequently induce
full activation in a CD8+ T cell that recognizes an epitope of the
same antigen, or a distinct antigen expressed on the same particle
or cell fragment which the antigen-presenting cell has endocytosed
(termed: linked recognition). The licensing interaction can be
conveyed via cell surface molecules such as CD40, or by soluble
cytokines such as IL-2 and IL-12 [5]. An alternative mechanism is
the delivery of signals direct from the CD4+ T cell to the CD8+ T
cell, if they have been approximated by interaction with the same
antigen-presenting cell (termed: the three cell cluster) [6].
After full activation, either through a licensed antigen-
presenting cell or in the direct presence of CD4+ T cells, CD8+
T cells must make local contact with pathogen-infected host cells.
This is critical since their cytotoxic effector function must be
focused on the pathogen-infected target cell, with minimal
engagement of other tissue cells. Thus, CD8+ T cells must
recirculate and localize to sites of infection. The in vivo localization
or homing of CD8+ T cells is controlled by selectin-addressin
interactions, which mediate initial attachment to vascular
endothelium and permit rolling, and by integrins that facilitate
firm adhesion. For example, CD8+ T cells recirculate from the
blood into lymph nodes through their expression of L-selectin,
which engages an addressin in the high endothelial venules of
lymph nodes [7]. In contrast, CD8+ T cells with the potential to
enter the intestine may express either the alpha4-beta7 integrin, or
the chemokine receptor CCR9 [8,9]. While CD4+ T cell help is
required for full CD8+ T cell function [10], it is less clear whether
CD4+ T cell help also participates in CD8+ T cell localization to
sites of effector function.
In the present study, we addressed the significance of CD4+ T
cell help in CD8+ T cell localization, using bioluminescent
imaging of Luciferase-transgenic CD8+ T cells. The expression of
a transgene encoding firefly Luciferase, and controlled by a strong
T cell-specific promoter, allowed us to determine the biodistribu-
tion of CD8+ T cells in albino mice. In parallel, we labeled CD8+
T cells with the dye CFSE, and used it to reveal cells that had
undergone multiple replication cycles, while co-staining for such
cells for integrins and chemokine receptors allowed us to visualize
the changes in the expression of such homing molecules that occur
in dividing T cells. The use of a replication-defective virus-based
vector allowed us to deposit the test antigen, ovalbumin, in skeletal
muscle, while transgenic CD8+ T cells expressing an ovalbumin-
specific antigen receptor made a local and systemic immune
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test the significance of ‘‘help’’, delivered by such CD4+ T cells, in
the CD8+ T cell response. We conclude that in addition to its
other effects, CD4+ T cell help affects the biodistribution of CD8+
T cells responding to antigen.
Results
Biodistribution of CD8+ T cells detected using
bioluminescence
To purpose of our study was to test the effect of CD4+ T cell
help on the location of CD8+ T cells during an immune response
to a replication-defective Herpes Simplex Virus (HSV) amplicon-
based vector that encodes ovalbumin [11]. To identify the location
of the CD8+ T cells in living mice, we used bioluminescent
transgenic T-lux T cells expressing firefly Luciferase [12], crossed
with a T cell receptor transgenic line, OT-1, specific for the
ovalbumin-derived antigenic peptide of sequence SIINFEKL.
These double-transgenic mice we term T-lux/OT-1 mice. To test
the role of CD4+ T cells, normal B6 mice were compared with
mice depleted of CD4+ T cells using anti-CD4 antibody. As an
alternative approach, we used B6 mice lacking the MHC class II
molecule, I-A
b, and therefore totally lacking CD4+ T cells. In the
case of mice treated with three daily injections of anti-CD4
antibody, the extent of depletion was verified using FACS analysis
of peripheral blood cells. In line with others using the same
antibody [13], we found that circulating CD4+ T cells were
effectively deleted. In contrast, control mice treated with vehicle
(saline) alone retained their CD4+ T cells.
Either anti-CD4-treated, or saline-treated control mice were
given 1610
6 units of HSV-based amplicon vector [14] given by
intramuscular (IM) injection into the right quadriceps femoris
muscle. The two vectors used were an experimental vector
expressing ovalbumin (HSVova), and a control vectors expressing
beta-galactosidase (HSVlac). Twenty-four hours later, the mice
received an intravenous (IV) injection of 1610
6 purified CD8+ T
cells from T-lux/OT-1 T mice. At various intervals after the
adoptive transfer, mice were imaged using a Xenogen-Caliper
IVIS-100 instrument [11].
In normal mice, bioluminescent signal was evident in various
superficial lymph nodes, including the cervical nodes, upon which
we focused since these nodes were readily identifiable, bilateral,
and did not drain the vector injection site. In addition, there was
strong bioluminescence that developed in the abdominal region
(Figure 1A, upper left panel). Our previous studies show that this is
due mostly to the accumulation of cells in the mesenteric lymph
nodes, with smaller signals from the milky spots in the omentum
and from the spleen [11]. The bioluminescence was stronger in
Figure 1. The biodistribution of T-lux/OT-1 CD8
+ cells during a primary immune response. (A) Mice were immunized with HSVova or
HSVlac, and 24 hr later infused intravenously with 1610
4 purified double transgenic naı ¨ve CD8
+ T cells, and then imaged using an IVIS imager. The
bioluminescent images represent the biodistribution of the CD8
+ cells on day seven. The control group of mice had their endogenous CD4+ T cells
present at the time of HSova immunization (left panel). The CD4 depleted group received three injection of anti-CD4 monoclonal antibody GK1.5
before they were immunized with HSVova (center panel). The MHC class II deficient mice lacking functional CD4+ T cells were similarly immunized
(right panel). Living image software allows the superimposition of elliptical regions of interest, within which the photon flux was measured. (B) Time
course of abdominal bioluminescence after administration of HSVova or HSVlac and 1610
4 T-lux/OT-1 CD8
+ cells. Data are representative of 6 to 12
individually analyzed mice, and are mean 6 SEM.
doi:10.1371/journal.pone.0016222.g001
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given HSVlac in which the bioluminescence was below the
threshold of detection (Figure 1A, upper right panel).
Deficiency of CD4+ T cells affected not only the level of
bioluminescence, but in particular its biodistribution, changing the
signal to a lesser extent in the cervical lymph nodes, but more
strikingly in the abdomen. Thus, anti-CD4+ antibody treatment
attenuated the signal (Figure 1A, lower left panel), and this effect
was evident from days 5 to 13 of the response (Figure 1B). Mice
that were MHC class II-deficient, and thus congenitally CD4+ T
cell deficient, made still weaker but detectable responses to
HSVova in the cervical lymph node, particularly on day 5
(Figure 1A, lower right panel).
While the effect of CD4+ T cell deficiency on bioluminescent
signal in the cervical lymph nodes was significant but partial
(Figure 1B, left panel), the effect on the bioluminescent signal in
the abdomen was total (Figure 1B, right panel). In normal control
mice, we detected a strong signal from the abdomen that was
significantly different from the signal in control vector (HSVlac)
treated mice, and maximal on day 7. In contrast, the CD4-
depleted mice, there was no increase in the abdominal
bioluminescence in HSVova treated mice. Similarly, there was
no detectable bioluminescent signal above background in the
abdomen of MHC class II deficient mice given the HSVova vector
and bioluminescent OT-1 T cells (Figure 1A and B). Taken
together, the different impact of CD4 deficiency on the antigen-
dependent bioluminescence of cervical lymph nodes versus the
abdominal region suggested that CD4+ T cells might influence the
in vivo biodistribution of CD8+ T cells.
The possibility of differential CD8+ T cell expansion
An alternative explanation for the differential effects of CD4+ T
cells in cervical versus abdominal lymphoid structures was that the
CD4+ T cells differentially affected proliferation in the two sites.
To test for this possibility, 1610
6 purified CFSE labeled OT-1
CD8
+ T cells were adoptively transferred into either intact or
CD4+ T cell-depleted mice that had previously been given
HSVova. At 72 hours after T cell administration, lymphoid tissues
were harvested: the inguinal lymph nodes (ILN), mesenteric lymph
nodes (MLN), cervical lymph nodes (CLN) and the spleen (SPL).
Activated OT-1 cells were obtained in all lymphoid tissue
examined, and the pattern of proliferation of CD8
+ antigen specific
T cells from both positive control and CD4 depleted mice were
similar (Figure 2A). However, the cell numbers obtained from MLN
and SPL were significantly less (p,0.05) in the CD4 depleted mice,
compared to control mice (Figure 2B). CD8
+ OT-1 T cells numbers
in the other lymphoid organs did not differ between the two groups
(Figure 2B). This result suggests that the lack of help from CD4
+ T
cells at the time of priming did not compromise CD8
+ proliferation,
sincethepattern ofCFSEdilutionwasthesame;this wasalsotrue of
the down regulation of CD62L (data not shown). However, there
werefewerOT-1 cellsinthe MLNand thespleen,both ofwhichare
sources of abdominal bioluminescence [11]. To account for the
differences in CD8+ T cell abundance in the absence of CD4+ T
Figure 2. In vivo OT-1 CD8
+T cells proliferation to HSVova in various secondary lymphoid organs. (A) Mice that received CFSE-labeled
naı ¨ve OT-1 CD8
+ T cell were immunized i.m. with HSVova. Three days post adoptive transfer of ova specific CD8
+ cells, the proliferation of CFSF-
labeled cells in mesenteric (MLN), inguinal (ILN) and cervical lymph nodes (CLN) and from the spleen (SPL) was visualized using flow cytometry. All
dot plots were gated on CD8
+ T cells. (B) Cell numbers obtained from MLN, ILN, CLN and SPL at day three post adoptive transfer of ova specific OT-1 T
cells. There were significantly fewer OT-1 cells in CD4-depleted mice in the MLN (** p,0.013) and the SPL (*p,0.005) but not the other lymph nodes.
Data are representative of six independent experiments (n=2 mice per group for each experiment).
doi:10.1371/journal.pone.0016222.g002
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considered the possibility that the CD4+ T cell help was protecting
the CD8+ T cells from death. However, testing for cellular markers
of apoptosis did not reveal any differences. Thus, we can best
explain the effects of CD4+ T cell help on the abundance of CD8+
T cells in specific tissue sites as a result of a selective effect on CD8+
T cell homing.
CD4
+ T cells modify expression of gut homing molecules
on CD8
+ T cells
Antigen engagement by naı ¨ve T cells results in changes in the
expression of homing and adhesion molecules. In particular,
activated T cells interacting with intestine-derived dendritic cells
selectively increased their expression of alpha4-beta7 integrin [15].
Since our experimental design made use of the adoptive transfer of
naı ¨ve OT-1 T cells, we were able to distinguish cells that have
undergone multiple division cycles using the dye CFSE. Therefore,
to test whether CD4
+ T cell help could be influencing the
biodistribution of CD8
+ T cell via effects on these molecules, we
analyzed the expression of gut homing molecules on CFSE-labeled
OT-1 T cells in ILN, CLN, MLN and SPL within 3 days after
adoptive transfer (Figure 3, left panels). There was increased
expression of the alpha4-beta7 integrin in the OT-1 cells that had
divided several times in MLN and spleen from normal control
mice, but less increase in CD4 depleted mice (Figure 3, left panels).
We compared geometric mean fluorescence intensity (GMFI) from
several round of divisions in control mice versus CD4-depleted mice
using a Mann Whitney test. The beta7 integrin chain up-
regulation was statistically significant for OT-1 cells in the MLN
in normal control mice (P=0.0022; Figure 4). The alpha4-beta7
integrin heterodimer, specifically associated with gut homing, was
also upregulated on the CD8
+ T cells that divided more than 4
times in MLN (Figure 5). In this case the expression was increased
overall in both control and CD4-depleted mice. We therefore
compared the division-associated differences in GMFI between
control and CD4+ depleted mice. We concluded that the
upregulation of this integrin was significantly greater in HSVova
treated control mice than in HSVova treated CD4-depleted mice
(p=0.0325). In view of this result we also tested the expression of
CCR9, which is frequently up-regulated on gut homing lympho-
cytes. The CCR9 molecule was indeed strongly up-regulated in
OT-1 T cells after cell division (Supplementary Figure S1).
However, unlike the alpha4-beta7 integrin, there was no clear
effect of CD4+ T cell depletion on CCR9 upregulation.
These data show that activated antigen specific CD8
+ T cells
acquired tissue specific homing molecules within the lymph nodes
4 days after ova inoculation. In control mice, the ability to re-
localize into intra-abdominal lymphoid organs increased after
several rounds of division, in parallel with the acquisition of tissue
specific homing molecules such as the beta7 integrin chain, and
the alpha4-beta7 integrin heterodimer. The ability of such CD8
+
T cells to up-regulate these gut homing markers was impaired in
CD4-deficient mice.
The effect of CD4+ T cell help in the CD8
+ T cell memory
response
To test whether CD4+ T cells, present during priming, had
effects on CD8+ T cell location that persisted in the memory
Figure 3. Expression of adhesion molecules on proliferating ova-specific CD8
+ T cells after HSVova. (A) Expression of alpha4-beta7
integrin (left) or the beta7 integrin chain (right) was assessed by flow cytometry on undivided (high CFSE) ova specific CD8
+ T cells, and on cells that
had undergone more than four divisions (low CFSE), taken from MLN and CLN from control mice. Integrin expression was revealed by staining with a
PE-conjugated antibody on day 4-post immunization. (B) The expression of adhesion molecules was analyzed by flow cytometry on undivided and
divided CD8
+ OT-1 cells in CD4 depleted mice. Comparing (A) with (B), there was a clear difference in the modal expression of alpha4-beta7 integrin
in the MLN.
doi:10.1371/journal.pone.0016222.g003
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peptide 45 days after priming. Mice were imaged before, and then
at time intervals after the secondary challenge with peptide, which
was given IP on three constitutive days, each dose being 25 nmol
of SIINFEKL diluted in 100 ml of saline. In the cervical lymph
nodes, we did not observe clear effects of CD4+ T cell depletion on
CD8+ T cell localization. Thus, the bioluminescent signal
appeared at first to be attenuated (but this effect was not
Figure 4. Changes in beta7 -integrin expression with cell division. Mice were immunized with HSVova i.m. and 24 hr later infused i.v. with
CFSE labeled CD8
+ T cells. Different lymphoid organs were taken out four days post HSVova. The level of beta7 -integrin expression was calculated as
the geometrical mean fluorescence intensity (GMFI) and is presented as a function of undivided (0) and more than 4 divisions, based on CFSE dilution.
Upregulation of beta7 integrin on CD8+ T cells from MLN was significant (p=0.0022) in control mice but not in CD4+ depleted mice. Mice were from
three experiments (n=2 mice per group per experiment).
doi:10.1371/journal.pone.0016222.g004
Figure 5. Changes in alpha4-beta7 integrin expression on dividing CD8
+ T cells. The level of expression of alpha4-beta7 integrin was
calculated as the geometrical mean fluorescence intensity and is presented as a function of cell division for each individual mouse. In the MLN, there
were increase in alpha4-beta7 integrin expression in both control and CD4+ treated mice, but the increase in GMFI was significantly greater in control
mice (p=0.0325). Data are from three experiments (n=2 mice per group per experiment). A GMFI of .0 implies fluorescence intensity lower than the
unstained control.
doi:10.1371/journal.pone.0016222.g005
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antibody treatment on day 2 post SIINFEKL (day 49 post
priming) but 2 days later, on day 52, it reached a level comparable
to control mice given the HSVova vector, and was in excess of
control mice that had received the HSVlac control vector (data not
shown). Overall, the bioluminescent signal in the CLN was not
significantly different between the anti-CD4 treated and the
untreated control mice (p=0.4).
In contrast to the lymph nodes, the effect of CD4+ T cell
depletion during priming was striking during the recall responses
in the abdominal lymphoid organs. In the HSVova positive
control mice, the photon flux in the abdominal region peaked four
day after challenge (day 51 post priming; Figure 6A and 6B), and
then declined towards the control level (HSVlac) by day eight. The
photon flux in the abdominal region peaked approximately 2-fold
higher than the primary response (compare Figure 1B with
Figure 6B), and the appearance of CD8+ T cells in abdominal sites
occurred earlier. In contrast, the CD4 depleted mice had much
lower bioluminescent signals measured in the abdominal region on
day four; this difference was statistically significant (p=0.04).
However, the most striking feature of the secondary response was
the delay in the response in the abdominal region in CD4-
depleted, compared to control HSVova-treated mice. The kinetics
of this response was in fact very similar to the accumulation of
bioluminescence in the abdomen in the normal control mice
during the primary response (compare Figure 6 with Figure 1).
Thus, CD4+ T cells were necessary for the localization of CD8+ T
cells to the abdomen both during the primary response, and
during a secondary response.
Discussion
The data presented here show that CD4+ T cells influence the
biodistribution of CD8+ T cells. This was shown using HSV-based
amplicon vectors, given IM into the quadriceps femoris, as the
antigen delivery vehicle. The CD8+ T cells were double-
transgenic, expressing both an antigen-specific T cell receptor
that recognizes an ovalbumin-derived peptide, and firefly
Luciferase [11]. An injection of the substrate, luciferin, resulted
in emission of visible light, which revealed the location of the
CD8+ T cells. The technique was performed under light general
anesthesia, permitting the individual mice to recover, and thereby
minimizing the number of mice required for a time-course study.
When CD4+ T cells were depleted using antibody, or were absent
in gene-targeted mice, there was reduced overall CD8+ T cell
abundance, but superimposed on this was a distinct effect on
CD8+ T cell location. Specifically, there was a modest loss of
bioluminescent signal from the cervical lymph nodes, but a total
loss of signal in the abdominal region. In a previous study, we
showed that abdominal bioluminescent in this experimental model
is due mainly to the mesenteric lymph nodes [11]. Therefore, in
the present experiments, the presence or absence of CD4+ T cell
help was modulating the localization of CD8+ T cells into the
mesenteric nodes.
The localization of activated CD8+ T cells to the mesenteric
nodes after several days in the immune response to a replication-
defective vector challenge in the hind limb is unlikely to be due to
migration of either antigen or antigen-presenting cells to these
nodes. A recent study shows that a tracer dye given into the hind
Figure 6. Bioluminescent imaging of the memory response. (A) Mice were re-challenged with 25 nM SIINFEKL peptide 45 days post priming
and biodistribution of T-lux/OT.1 cells was determined using in vivo imaging. The images represent individual mice from day four-post challenge (51
days post priming). Bioluminescent signals in HSVova mice were distributed mostly in the abdominal region, in contrast to the CD4 depleted mouse.
(B) Time course of abdominal bioluminescence of T-lux/OT.1 cells after administration of SIINFEKL peptide. The data are from two experiments (n=3
mice per group in each experiment). In HSVova-treated positive control mice, the photon flux peaked by day 6 post secondary challenge; however
the signal from CD4 depleted mice was significantly lower at early times but peaked 8 days later.
doi:10.1371/journal.pone.0016222.g006
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and subsequently drains to the iliac nodes [16]. These iliac lymph
nodes are indeed deep abdominal structures, but they do not
constitute the majority of the bioluminescence in an anti-HSV
amplicon response, as we showed previously [11]. Therefore, in
the presence of CD4+ T cells the localization of the CD8+ T cells
to the abdomen in most likely driven not by antigen, but by cell-
intrinsic homing properties.
This change in CD8+ T cell abundance in different tissue sites
could have resulted from several mechanisms. We tested for, and
excluded a potential mechanism based on differential T cell
division in the cervical versus mesenteric nodes, using the dye CFSE
to stain T cells and dilution of the dye to indicate cell proliferation.
We also tested the possibility that CD4+ T cell help was
influencing the expression of cell surface adhesion molecules,
and found that in the presence of CD4+ T cells, the dividing
CD8+ T cells increased the expression of the alpha4-beta7
integrin, which is associated with homing of CD8+ T cells to the
intestine. This was confirmed using a second antibody specific for
the beta7 integrin chain alone. Other markers of cell activation or
homing potential were not so clearly affected. We conclude that
the CD4+ T cells were most likely modulating CD8+ T cell
localization through an effect on homing, mediated in particular
by alpha4-beta7 integrin.
The immune responses of CD8
+ T cells are sometimes strictly
CD4
+ T cell help-dependent, and sometimes more-or-less CD4
+
help-independent, based on the nature of the immune stimulus.
Help-independent responses are typical of those to an infectious
agent, such as the bacterium, Listeria monocytogenes [17], while the
help-dependent response was typical for non-inflammatory
antigens, such as minor histocompatibility antigens [18,19]. A
consensus is emerging in which, in the absence of the innate
immune activation signals delivered to antigen presenting cells,
help from CD4
+ T cells is a requirement for an effective CD8
+ T
cells response. The level of inflammation involved in different
experimental model systems may also modulate the help-
dependence of CD8
+ T cells.
The interaction of CD4+ T cells with CD8+ T cells may be
mediated via dendritic cells, which are central in naı ¨ve T cell
activation under most circumstances. This model that explains this
3-cell interaction, termed ‘‘licensing’’, was proposed more than 10
years ago[20,21,22]. In this model, interaction of CD40 with its
counterpart, CD40L, which is expressed on CD4
+T cells, leads to
maturation of dendritic cells. However, in the case of viruses, the
pathogen can induce signals via Toll-like receptors without help
from CD4 for maturation of dendritic cells [23,24]. Such dendritic
cells have the ability to distinguish the pathogen signals and
influence the characteristics of the T cell responses that they
induce [25]. Several studies using soluble antigen, such as
ovalbumin, have reported tissue-specific combinations of adhesion
molecules and chemokine cues resulting in selective recruitment of
CD4
+ T cells to either the gut or the skin [26,27]. These primed
CD4
+ T cells of the intestinal lymph nodes have up-regulated
expression of integrin alpha4-beta7; however, CD4
+ T cells that
were primed in the skin lymph nodes have a high expression of P-
selectin ligands [28]. In the case of CD8
+ T cells, in vitro priming
studies reported that dendritic populations are important in
determining whether gut or skin homing phenotypes are on the
primed CD8
+ T cells [15,29,30]. Thus, bone marrow-derived
peptide-pulsed dendritic cells injected via different routes of
delivery resulted in up-regulation of different homing phenotypes
on primed CD8
+ T cells in vivo [29]. In the context of the present
study, we therefore think it is likely that dendritic cells in the
popliteal and/or inguinal draining lymph nodes impose upon
OT-1 CD8+ T cells the changes in alpha4-beta7 integrin
expression that predispose the cells to homing to abdominal
lymphoid structures.
The role of CD4
+ T cell help in generating memory CD8
+ T
cells also varies between different experimental models. Early
reports suggested that CD4
+ T help is essential for the generation
of functional CD8
+ T cell memory to most antigens [13,31], and
that un-helped CD8
+ T cells make a poor memory response upon
secondary challenge [31]. However, in other experiments, un-
helped CD8
+ T cells had the ability to proliferate after secondary
challenge [32]. As in the case of primary responses, these
discrepancies best fit a model in which accessory signals determine
the requirement for CD4
+ T cell help.
The concept that CD4+ T cell help for CD8+ T cells is
mediated by licensing of dendritic cells implies the recognition of
antigen that is presented to the CD4+ T cell by the dendritic cell.
Thus, the antigen specificity of the CD4+ T cell would be crucial
for this kind of help. Our CD4+ T cell depletion experiments did
not distinguish between antigen-specific and non-specific help, and
it may have been better not to exclude either. The role of antigen-
specificity in CD4+ T cell help for CD8+ T cells is ambiguous; one
study showed that the presence but not the specificity of CD4+ T
cells was important in long-term CD8+ T cell memory [33].
Another showed that heterospecific CD4+ T-helper cells could
deliver help to CD8+ T cells [34].
The observation that a brief antigen exposure could result in
clonal expansion of naive CD8
+ T cells, followed by effector
functions and memory cells, gave rise to the concept of
‘‘programming’’ [35]. In this concept, a fully-activated naı ¨ve
CD8
+ T cell needs no further antigenic signal to execute its full
differentiation program. It was suggested that the CD4
+ T help
was crucial at an early time point, during initial CD8
+ T cell
priming, and that this could influence the later development of
memory CD8
+ T cells [13]. However, not all experiments
supported a programming model for CD4
+ T cell help; other
studies were more consistent with the concept that CD4
+ T help
was necessary for maintaining, rather than programming CD8
+ T
cell memory [33].
After priming, activated T cells enter the circulation and
migrate to many tissues, including secondary lymphoid organs and
non-lymphoid tissue. Studies by Masopust and colleagues [36]
show that virus specific effector and memory T cells are present in
a wide range of host tissues, regardless of the route of viral
infection. In our data, we observed an effect of CD4+ T cell
depletion during the initial priming of CD8+ T cells that was
manifest in the memory phase, almost 60 days later. This was a
time at which the CD4+ T cells had recovered from antibody
depletion. Therefore, we think these effects fit with the idea of
programming. Our working hypothesis is that CD4+ T cell help
programs CD8+ T cells for specific homing, particularly to the
mesenteric lymph nodes. In the absence of such programming,
primed CD8+ T cells do not go there.
On the basis of the data presented here, we speculate that CD4+
T cell help for CD8+ T cells entails an element that we propose to
call ‘‘programming for location’’. While we have observed this
only in a vector-driven model, it may be a general feature of
helper-dependent CD8+ T cell responses. If this model is correct,
programming for location may contribute to why CD4+ T cell
help is important in effective CD8+ T cell-mediated immunity, for
example to pathogens such as Hepatitis C Virus, in which some
individuals eradicate infection, others fail to do so, and the
difference is closely associated with the presence or absence of a
CD4+ T cell response.
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Ethics Statement
All animal experiments were approved by the Institutional
Animal Care and Use Committee.
Mice
C57BL/6J-Tyrc-2J/J albino mice were purchased from Jackson
Laboratory (Bar Harbor, ME, USA) and were kept in the
University of Rochester SPF vivarium. MHC class II-deficient
mice were obtained from Taconic Farms (Germantown, NY,
USA) and were backcrossed three times to C57BL/6L-tyrc-2J/J in
order to have MHC class II deficient mice with an albino coat. For
in vivo imaging experiments, the lack of melanin pigment in these
albino mice increased the sensitivity of detection substantially.
Luciferase-expressing transgenic mice (T-lux mice) [12] were a
kind gift from Dr. Casey Weaver (University of Alabama
Birmingham, AL, USA). A colony of OT-1 TCR transgenic mice
[37] was maintained on a CD45.1 background. Crossing H-2
b T-
lux mice with OT-1 TCR transgenic mice generated double-
transgenic mice, in which the CD8
+ T cells were specific for the
SIINFEKL peptide of ovalbumin and all T cells expressed the
Luciferase reporter gene. These mice were CD45.1 x CD45.2
heterozygous, and are termed T-lux/OT-1. T cells from T-lux/
OT-1 were identified in host mice, based on CD45.1 expression.
Flow cytometry
Mice were typed using the allotypic marker CD45.1 (clone A20)
PE conjugated, TCR Valpha2 (clone B20.1) PE-conjugated,
Vbeta5 (clone MR9-4) FITC conjugated and CD8a (clone 53-
6.7) PerCP conjugated antibodies from BD PharMingen (San Jose,
CA, USA). Data were acquired using a FACSCaliburH (Becton
Dickinson Immunocytometry System, San Jose, CA, USA).
Antibodies to the murine alpha4-beta7 heterodimer (clone
DATK32), and beta7 (clone M293) integrin chains were from BD
Pharmingen (San Jose, CA, USA). Both integrin antibodies were
PE-conjugated. Lymphoid organs were harvested on day three-
post adoptive CD8
+ T cell transfer; these were the inguinal lymph
nodes (ILN), mesenteric plus lumbar nodes (MLN), cervical lymph
nodes (CLN) and the spleen (SPL). These tissues were homoge-
nized mechanically and cells re-suspended in Hanks Balanced Salt
Solution (HBSS) containing 5% heat inactivated fetal bovine
serum. Cell suspensions were counted, and incubated with Live/
DEAD stain (Invitrogen, Eugene, OR, USA) before surface
marker antibody staining. Subsequently, cells were washed with
PBS and re-suspended in PBS for FACS analysis using a
LSRII
TM(BD Biosciences, San Jose, CA, USA). Doublets were
excluded based on a gate on forward height versus area, and viable
lymphocytes were identified using a gate based on forward and
side scatter, and by using the Live/Dead staining reagent.
Bioluminescence imaging and image analysis
Mice were anesthetized with intraperitoneally (i.p.) injection of
ketamine (100 mg/kg body weight) and xylazine (10 mg/kg body
weight) and then given an i.p. injection of D-luciferin (214 mg/g
body weight; Xenogen-Caliper corp., Alameda, CA, USA). After
5 min, the mice were positioned in the imaging chamber (IVIS-
100 series) for data collection. Briefly, the IVIS-100 series consists
of a cooled CCD camera mounted on a light-tight chamber, a
cryogenic unit for camera refrigeration and a computer for image
collection and analysis. The acquisition time was 5 min both for
the primary response and for the secondary challenge. Biolumi-
nescence data were obtained using medium binning, for high
resolution but at the cost of loss of some sensitivity. Relative
intensities of emitted light were represented as pseudocolor images
ranging from red (most intense) to blue (least intense). Gray scale
photographs and the corresponding pseudocolor images were
superimposed with Living Image (Xenogen-Caliper) and Igor
(waveMetrics, Lake Oswego, OR, USA) image analysis software.
Signal emitted by regions of interest (ROI) was measured and data
were expressed as photo flux and quantified as photon sec
21 cm
22
sr
21. The steradian (sr) term refers to photons emitted from a unit
solid angle of a sphere. Data were shown as mean 6 SEM. The
machine background was subtracted electronically both from the
images and from the measurements of photon flux.
Herpes Simplex-based Amplicon Vectors
Helper-free herpes simplex virus type 1 (HSV-1) based
amplicon vectors encoding the test antigen ovalbumin were
assembled in the Center for Neural Development and Disease,
Amplicon Vector Production Core at University of Rochester
(Rochester, NY, USA). The HSV amplicon consists of the HSV-
derived immediate-early 4/5 promoters, which drive the expres-
sion of the ova gene (termed HSVova) or control HSV amplicon
expressing beta-galactosidase (termed HSVlac). The amplicon can
transduce a variety of tissues including post-mitotic neurons [38].
Amplicon stock construction and the estimation of vector
concentration was described previously [14,39,40].
Immune Response to HSV Amplicons
We previously established an in vivo imaging protocol in which
the immune response of adoptively transferred, double transgenic
CD8
+ T cells (T-lux/OT-1) against ova was visualizes non-
destructively after IM inoculation of HSV-based amplicons [11].
Activated double transgenic CD8
+ T cells, T-lux/OT-1, respond-
ed to HSVova and could be detected in injection site, inguinal
lymph node and intra-abdominal organs. We could detect
dispersion of the cells systemically, but a majority of cells remained
within abdomen.
To document the duration of antigen expression, purified
transgenic CD8
+ T cells were transferred IV either 1 or 13 days
after HSVova injection. Measurement of bioluminescent signal
from intra-abdominal structures at 1 day post immunization
resulted in maximal photon flux in the abdominal region by day 5
post cell transfer. In contrast there was no signal above baseline in
immunized mice that received T-lux/OT-1 CD8
+ T cells 13 days
after HSVova (data not shown). These data show that expression
of the HSV-encoded Ag was transient, even without exogenous T
cells. The disappearance of antigen within 13 days is consistent
with a previous report using HSV amplicon expressing Luciferase,
in which the maximum signal from IM inoculation of HSVlac was
at 24 hr and it declined rapidly thereafter [41].
Adoptive Transfer and cell proliferation assay
Peripheral lymph node and spleen cells were harvested from
either OT-1 or T-lux/OT-1 mice. A single cell suspension was
prepared by mechanical homogenization of tissues, and red blood
cells were removed using Lympholyte M (Cedarlane Laboratories,
Burlington, NC, USA). Naive purified CD8
+ T cells were obtained
using negative selection via Miltenyi MACS purification kits
(Miltenyi Biotech Inc., Auburn, CA, USA) according to the
manufacturers’ protocol. To detect T cell proliferation in vivo,
purified CD8
+ T cells were labeled with 5 micromolar CFSE
(Molecular Probes, Eugene, OR, USA) at 37uC for 10 min and
washed three times before IV transfer to the recipients. In the
bioluminescent imaging experiments, recipient mice were given
1610
4 purified double transgenic CD8
+ T cells, and for in vivo
proliferation 1610
6 purified transgenic CD8
+ T cells.
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+ T cells
GK1.5 (anti-CD4) hybridoma was grown in BD serum-free
medium, then transferred to BD CELLine culture system (BD
biosciences, Sparks, MD). Culture supernatant was harvested and
pooled for antibody production. Pooled supernatant was purified
by 50% ammonium sulfate precipitation, and dialysis. Antibody
titer was measured by ELISA, and the antibody was sterilized by
filtration. CD4
+ cell depletion was achieved by i.p. injection of 50
micrograms of purified GK1.5 in 0.1 ml of PBS, given on three
constitutive days prior to immunization. The effectiveness of
depletion was monitored by staining peripheral blood with a non-
competing anti-CD4 mAb (clone RM4-4) and anti CD3 (Clone
145-2C11) using a FACSCaliburH flow cytometer and CellQuest
software. Both antibodies were purchased from BD Pharmingen
(San Jose, CA, USA).
Peptide
The SIINFEKL peptide, corresponding to residues OVA 257–264,
was purchased from New England Peptide (Fitchburg, MA, USA)
and mice were re-challenged with daily i.p. injections of 25 nmol of
peptide for 3 days.
Statistical Analysis
Bioluminescence data were pooled from multiple experiments
and expressed graphically as mean 6 SEM. The Mann Whitney
test was used to measure the significance of difference observed
between the experimental groups. Statistical analysis was per-
formed using Prism software (GraphPad Software, Inc., La Jolla,
CA, USA).
Supporting Information
Figure S1 The absence of CD4+ T cell help does not affect the
up-regulation of the CCR9 chemokine receptor. CFSE versus
CCR9 staining was used to identify OT-1 T cells that had divided
4 or more times. The geometric mean fluorescence index (GMFI)
was increased in dividing T cells in all of the lymph nodes
examined, but unlike the case for alpha4-beta7 integrin, there was
no significance difference between intact positive control mice and
mice that were CD4-depleted.
(TIF)
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